NICE Ltd.

NASDAQ:NICE

Software - Application

Technology
$91.61 +0.55%

+$0.46 today

Market cap
$5.25B
Beta
0.01
P/E (TTM)
9.5
EPS (TTM)
$8.89
52W Low $83.10High $175.00

Volume 0.83M

Average 0.70M

NICE Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

NICE Ltd.NASDAQ: NICE

Research & Development · Q2 FY2026 · quarter ended Jun 2026

Research & development growth accelerates

Q2 FY2026 research & development of $104.59M rose 16.5% year over year, ahead of the +5.0% change in trailing-twelve-month research & development. Sequentially, it rose 7.6% from the prior quarter. Over 3 fiscal years it compounded at +5.6% a year.

Context

  • Research & development amounted to 12.2% of revenue in FY2025, down 0.9 pp from a year earlier.
  • Research & development increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +16.5% holds above the trailing-twelve-month pace of +5.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$104.59M+7.6% QoQ
Last fiscal yearDec 2025
$360.45M-0.0% YoY
LTMJun 2026
$383.39M+5.0% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+16.5%——
1 year-0.0%——
3-year CAGR+5.6%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
360.45M USD
Year-over-year change
-0.0%
4-year CAGR
+7.4%

Research & Development vs competitors

How NICE compares with its peers on the latest reported figures

  • NICE's LTM Jun 2026 research & development of $383.39M is the highest of the 6 companies compared; the peer median is $118.54M.
  • Its year-over-year change of +5.0% is the 3rd highest of 4, against a peer median of +14.8%.
  • Research & development amounts to 12.4% of revenue for NICE, versus a peer median of 8.7%.
NICE Competitors Peer median
Research & Development for NICE and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NICENICE Ltd.LTM Jun 2026$383.39M +5.0%+5.6%12.4%
FICOFair Isaac CorporationLTM Jun 2026$208.49M +14.8%+8.7%8.7%
ACIWACI Worldwide, Inc.LTM Sep 2026$187.08M +16.1%+4.6%10.6%
NCNOnCino, Inc.LTM Jul 2026$118.54M -11.0%+1.6%19.1%
NDAQNasdaq, Inc.LTM Sep 2026$0 ——0.0%
VRSKVerisk Analytics, Inc.LTM Jun 2026$0 ——0.0%
Peer median (excluding NICE) $118.54M+14.8%+4.6%8.7%

Competitors are the stored peer set for NICE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.92B2.18B2.38B2.74B2.95B
Cost of Revenue624.46M683.69M768.17M909.52M989.25M
Gross Profit1.3B1.5B1.61B1.83B1.96B
Gross Margin67.5%68.7%67.7%66.7%66.4%
Research & Development271.19M306.07M322.71M360.61M360.45M
Selling, General & Admin761.6M856.36M851.4M916.41M949.94M
Operating Expenses1.03B1.16B1.17B1.28B1.31B
Depreciation & Amortization184.09M176.55M167.36M205.02M199.04M
EBITDA440.48M525.59M628.76M754.14M903.06M
EBITDA Margin22.9%24.1%26.4%27.6%30.7%
Operating Income263.91M335.17M435.23M545.95M645.76M
Operating Margin13.7%15.4%18.3%20.0%21.9%
Interest Income13.95M18.38M34.07M64.98M54.47M
Interest Expense33.31M9.69M8.18M5.27M0
Other Income / Expenses(23.29M)10.16M22.47M58.87M58.26M
Income Before Tax240.62M345.33M457.7M604.83M704.02M
Pre-Tax Margin12.5%15.8%19.3%22.1%23.9%
Income Tax Expense41.4M79.39M119.4M162.24M91.92M
Net Income199.22M265.95M338.3M442.59M612.1M
Net Margin10.4%12.2%14.2%16.2%20.8%
EPS (Basic)3.154.175.326.979.82
EPS (Diluted)2.984.005.116.769.67
Weighted Avg Shares63.19M63.79M63.59M63.48M62.33M
Weighted Avg Shares (Diluted)66.9M66.47M66.27M65.51M63.32M

NICE Ltd.

NASDAQ:NICE

Intrinsic Alpha fair value

Locked

Current Price

$91.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.